JW Pharmaceutical Corp (001065) — Tangible Net Worth Ratio
JW Pharmaceutical Corp (001065) has a Tangible Net Worth Ratio of 84.4% as of September 2025. This metric is calculated by deducting intangible assets (₩55.38 Billion) from net assets (₩354.10 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See JW Pharmaceutical Corp working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
JW Pharmaceutical Corp Tangible Net Worth Ratio (2014–2024)
This chart shows how JW Pharmaceutical Corp's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 84.4%, reflecting net assets of ₩354.10 Billion with intangible assets of ₩55.38 Billion KRW. See JW Pharmaceutical Corp liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for JW Pharmaceutical Corp (2014–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for JW Pharmaceutical Corp from 2014 to 2024, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of JW Pharmaceutical Corp.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.6% | ₩329.49 Billion | ₩40.84 Billion | ₩604.60 Billion | ▼ -1.5 pp |
| 2023 | 89.1% | ₩265.44 Billion | ₩28.95 Billion | ₩645.04 Billion | ▼ -3.7 pp |
| 2022 | 92.8% | ₩225.76 Billion | ₩16.27 Billion | ₩627.97 Billion | ▲ +4.2 pp |
| 2021 | 88.6% | ₩188.54 Billion | ₩21.47 Billion | ₩633.05 Billion | ▼ -2.9 pp |
| 2020 | 91.5% | ₩207.47 Billion | ₩17.67 Billion | ₩549.09 Billion | ▼ -2.3 pp |
| 2019 | 93.8% | ₩230.09 Billion | ₩14.35 Billion | ₩573.21 Billion | ▼ -0.4 pp |
| 2018 | 94.2% | ₩260.11 Billion | ₩15.14 Billion | ₩593.79 Billion | ▲ +1.6 pp |
| 2017 | 92.6% | ₩270.78 Billion | ₩20.14 Billion | ₩630.87 Billion | ▲ +1.0 pp |
| 2016 | 91.5% | ₩276.31 Billion | ₩23.39 Billion | ₩651.08 Billion | ▼ -4.9 pp |
| 2015 | 96.4% | ₩225.41 Billion | ₩8.10 Billion | ₩613.48 Billion | ▲ +0.2 pp |
| 2014 | 96.2% | ₩220.02 Billion | ₩8.30 Billion | ₩589.24 Billion | — |